Carles J - Search Results

1

Multicenter study evaluating a dual policy of postorchiectomy surveillance and selective adjuvant single-agent carboplatin for patients with clinical stage I seminoma.

Aparicio J, García del Muro X, Maroto P, Paz-Ares L, Alba E, Sáenz A, Terrasa J, Barnadas A, Almenar D, Arranz JA, Sánchez M, Fernández A, Sastre J, Carles J, Dorca J, Gumà J, Yuste AL, Germà JR; Spanish Germ Cell Cancer Cooperative Group (GG). Aparicio J, et al. Among authors: carles j. Ann Oncol. 2003 Jun;14(6):867-72. doi: 10.1093/annonc/mdg241. Ann Oncol. 2003. PMID: 12796024 Free article.

2

Phase II feasibility study of high dose epirubicin plus etoposide and cisplatin (HDEEC) regimen in small cell lung cancer.

Rosell R, Carles J, Abad A, Jimeno JM, Moreno I, Barnadas A, Ribelles N, Haboubi N. Rosell R, et al. Among authors: carles j. Invest New Drugs. 1992 Jul;10(2):123-8. doi: 10.1007/BF00873130. Invest New Drugs. 1992. PMID: 1323550 Clinical Trial.

3

A phase II study of days 1 and 8 cisplatin and recombinant alpha-2B interferon in advanced non-small cell lung cancer.

Rosell R, Carles J, Ariza A, Moreno I, Ribelles N, Solano V, Pellicer I, Barnadas A, Abad A. Rosell R, et al. Among authors: carles j. Cancer. 1991 May 15;67(10):2448-53. doi: 10.1002/1097-0142(19910515)67:10<2448::aid-cncr2820671009>3.0.co;2-2. Cancer. 1991. PMID: 1707745 Clinical Trial.

4

Randomized trial for the control of acute vomiting in cisplatin-treated patients: high-dose metoclopramide with dexamethasone and lorazepam as adjuncts versus high-dose alizapride plus dexamethasone and lorazepam. Study of the incidence of delayed emesis.

Moreno I, Rosell R, Abad-Esteve A, Barnadas A, Carles J, Ribelles N. Moreno I, et al. Among authors: carles j. Oncology. 1991;48(5):397-402. doi: 10.1159/000226967. Oncology. 1991. PMID: 1745488 Clinical Trial.

5

Sequential combination of methotrexate (MTX), 5-fluorouracil (FU), and high-dose folinic acid (FA) in advanced colorectal cancer: double biochemical modulation?

Abad A, Rosell R, Pastor MC, Barnadas A, Carles J, Ribelles N, Oller B, Armengol M, Salva A, Ribas M. Abad A, et al. Among authors: carles j. Am J Clin Oncol. 1991 Oct;14(5):393-6. doi: 10.1097/00000421-199110000-00006. Am J Clin Oncol. 1991. PMID: 1951176 Clinical Trial.

6

5-fluorouracil, ifosfamide and mitomycin (FIM) combination for pancreatic-biliary tumors.

Abad A, Rosell R, Barnadas A, Carles J, Ribelles N, Solano V. Abad A, et al. Among authors: carles j. Ann Oncol. 1991 Feb;2(2):153. doi: 10.1093/oxfordjournals.annonc.a057881. Ann Oncol. 1991. PMID: 2054318 Free article. No abstract available.

7

A randomized study of two vindesine plus cisplatin-containing regimens with the addition of mitomycin C or ifosfamide in patients with advanced non-small cell lung cancer.

Rosell R, Abad-Esteve A, Moreno I, Barnadas A, Carles J, Fernandez C, Ribelles N, Culubret M. Rosell R, et al. Among authors: carles j. Cancer. 1990 Apr 15;65(8):1692-9. doi: 10.1002/1097-0142(19900415)65:8<1692::aid-cncr2820650805>3.0.co;2-x. Cancer. 1990. PMID: 2156597 Review.

8

Cyclophosphamide and ifosfamide combination as neoadjuvant chemotherapy for locally advanced nonsmall-cell lung cancer: a meta-analytic review.

Rosell R, Moreno I, Maestre J, Olazabal A, Carles J, Barnadas A, Abad-Esteve A, Ribelles N, Canela M. Rosell R, et al. Among authors: carles j. J Surg Oncol. 1990 Oct;45(2):124-30. doi: 10.1002/jso.2930450213. J Surg Oncol. 1990. PMID: 2170771

9

Neuroendocrine differentiation as a prognostic factor in non-small cell lung cancer.

Carles J, Rosell R, Ariza A, Pellicer I, Sanchez JJ, Fernandez-Vasalo G, Abad A, Barnadas A. Carles J, et al. Lung Cancer. 1993 Dec;10(3-4):209-19. doi: 10.1016/0169-5002(93)90181-v. Lung Cancer. 1993. PMID: 7521264

10

Gemcitabine/paclitaxel-based three-drug regimens in advanced urothelial cancer.

Bellmunt J, Guillem V, Paz-Ares L, González-Larriba JL, Carles J, Albanell J, Tabernero JM, Cortés-Funes H, Baselga J. Bellmunt J, et al. Among authors: carles j. Eur J Cancer. 2000 Jul;36 Suppl 2:17-25. doi: 10.1016/s0959-8049(00)00081-2. Eur J Cancer. 2000. PMID: 10908844 Review.

Save citations to file

Email citations

Send citations to clipboard

Add to Collections

Add to My Bibliography

Create a file for external citation management software

Your saved search

Your RSS Feed

My NCBI Filters

Text availability

Article attribute

Article type

Publication date

291 results

Search Page